Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis.

Kvistad SS, Myhr KM, Holmøy T, Benth JŠ, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Sagen JV, Torkildsen Ø.

J Neuroimmunol. 2018 Oct 15;323:73-77. doi: 10.1016/j.jneuroim.2018.07.011. Epub 2018 Jul 24.

PMID:
30196837
2.

α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients.

Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø.

Mult Scler. 2018 May 1:1352458518779925. doi: 10.1177/1352458518779925. [Epub ahead of print]

PMID:
29862891
3.

Do Patients With Chronic Low Back Pain Benefit From Early Intervention Regarding Absence From Work?: A Randomized, Controlled, Single-Center Pilot Study.

Norbye AD, Omdal AV, Nygaard ME, Romild U, Eldøen G, Midgard R.

Spine (Phila Pa 1976). 2016 Nov 1;41(21):E1257-E1264.

4.

Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom.

Cortese M, Riise T, Bjørnevik K, Bhan A, Farbu E, Grytten N, Hogenesch I, Midgard R, Smith Simonsen C, Telstad W, Ascherio A, Myhr KM.

Ann Neurol. 2016 Oct;80(4):616-24. doi: 10.1002/ana.24769.

PMID:
27554176
5.

No association of tobacco use and disease activity in multiple sclerosis.

Kvistad S, Myhr KM, Holmøy T, Benth JŠ, Løken-Amsrud KI, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Torkildsen Ø.

Neurol Neuroimmunol Neuroinflamm. 2016 Jul 14;3(4):e260. doi: 10.1212/NXI.0000000000000260. eCollection 2016 Aug.

6.

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.

Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N.

Mult Scler. 2017 Feb;23(2):213-219. doi: 10.1177/1352458516646863. Epub 2016 Jul 11.

7.

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.

Wergeland S, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Kvistad SS, Holmøy T, Riise T, Torkildsen Ø.

Eur J Neurol. 2016 Jun;23(6):1064-70. doi: 10.1111/ene.12986. Epub 2016 Mar 21.

PMID:
26998820
8.

Body mass index influence interferon-beta treatment response in multiple sclerosis.

Kvistad SS, Myhr KM, Holmøy T, Šaltytė Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, Sagen JV, Torkildsen Ø.

J Neuroimmunol. 2015 Nov 15;288:92-7. doi: 10.1016/j.jneuroim.2015.09.008. Epub 2015 Sep 26.

PMID:
26531700
9.

WT1 and interferon-β-vitamin D association in MS: a longitudinal study.

Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltytė-Benth J, Hovdal H, Myhr KM.

Acta Neurol Scand. 2016 Apr;133(4):309-12. doi: 10.1111/ane.12448. Epub 2015 Jun 2.

PMID:
26037530
10.

Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltytė Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T.

J Neuroimmunol. 2015 Mar 15;280:21-8. doi: 10.1016/j.jneuroim.2015.02.001. Epub 2015 Feb 11.

PMID:
25773151
11.

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.

Torkildsen O, Aarseth J, Celius EG, Holmøy T, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Riise T, Grytten N.

Ann Clin Transl Neurol. 2014 May;1(5):376-7. doi: 10.1002/acn3.56. Epub 2014 Apr 10. No abstract available.

12.

Month of birth and risk of multiple sclerosis: confounding and adjustments.

Torkildsen O, Aarseth J, Benjaminsen E, Celius E, Holmøy T, Kampman MT, Løken-Amsrud K, Midgard R, Myhr KM, Riise T, Grytten N.

Ann Clin Transl Neurol. 2014 Feb;1(2):141-4. doi: 10.1002/acn3.37. Epub 2014 Feb 4.

13.

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.

Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O.

Mult Scler. 2014 Dec;20(14):1833-40. doi: 10.1177/1352458514533843. Epub 2014 May 19.

PMID:
24842958
14.

Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T.

J Neuroimmunol. 2014 Jun 15;271(1-2):60-5. doi: 10.1016/j.jneuroim.2014.03.014. Epub 2014 Mar 24.

PMID:
24713402
15.

Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity.

Holmøy T, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Saltytė Benth J, Torkildsen O, Wergeland S, Myhr KM, Michelsen AE, Aukrust P, Ueland T.

PLoS One. 2013 Sep 19;8(9):e75021. doi: 10.1371/journal.pone.0075021. eCollection 2013.

16.

Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction.

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JŠ, Torkildsen Ø, Wergeland S, Holmøy T.

PLoS One. 2013;8(1):e54417. doi: 10.1371/journal.pone.0054417. Epub 2013 Jan 22.

17.

Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.

Kampman MT, Aarseth JH, Grytten N, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Torkildsen O.

J Neurol. 2013 Jun;260(6):1481-8. doi: 10.1007/s00415-012-6814-x. Epub 2013 Jan 6.

PMID:
23292231
18.

Incidence and prevalence of multiple sclerosis in Norway.

Midgard R.

Acta Neurol Scand Suppl. 2012;(195):36-42. doi: 10.1111/ane.12025. Review.

PMID:
23278655
19.

Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.

Grytten N, Torkildsen Ø, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Kampman MT.

Mult Scler. 2013 Jul;19(8):1028-34. doi: 10.1177/1352458512471094. Epub 2012 Dec 20.

PMID:
23257620
20.

Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Holmøy T.

Mult Scler. 2013 Apr;19(4):451-7. doi: 10.1177/1352458512457843. Epub 2012 Aug 20.

PMID:
22907941
21.

Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients.

Saltytė Benth J, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Holmøy T.

Neuroepidemiology. 2012;39(2):84-93. doi: 10.1159/000339360. Epub 2012 Jul 17.

22.

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.

Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Sandvik L, Torkildsen O, Wergeland S, Myhr KM.

Neurology. 2012 Jul 17;79(3):267-73. doi: 10.1212/WNL.0b013e31825fdf01. Epub 2012 Jun 13.

PMID:
22700809
23.

Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population.

Maniaol AH, Elsais A, Lorentzen ÅR, Owe JF, Viken MK, Sæther H, Flåm ST, Bråthen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF.

PLoS One. 2012;7(5):e36603. doi: 10.1371/journal.pone.0036603. Epub 2012 May 9.

24.

ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.

Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Lilleås F, Pedersen T, Bjørnarå B, Dalene F, Kleveland G, Schepel J, Olsen IC, Myhr KM.

Arch Neurol. 2012 Aug;69(8):1044-51. doi: 10.1001/archneurol.2012.283.

PMID:
22507886
25.

Incidence and clinical features of amyotrophic lateral sclerosis in Møre and Romsdal County, Norway.

Gundersen MD, Yaseen R, Midgard R.

Neuroepidemiology. 2011;37(1):58-63. doi: 10.1159/000329523. Epub 2011 Aug 22.

PMID:
21860251
26.

Risk of MS is not associated with exposure to crude oil, but increases with low level of education.

Riise T, Kirkeleit J, Aarseth JH, Farbu E, Midgard R, Mygland Å, Eikeland R, Mørland TJ, Telstad W, Førland PT, Myhr KM.

Mult Scler. 2011 Jul;17(7):780-7. doi: 10.1177/1352458510397686. Epub 2011 Feb 22.

PMID:
21343231
27.

Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway.

Risberg G, Aarseth JH, Nyland H, Lauer K, Myhr KM, Midgard R.

Acta Neurol Scand. 2011 Oct;124(4):250-7. doi: 10.1111/j.1600-0404.2010.01465.x. Epub 2010 Dec 10.

PMID:
21143594
28.

Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway.

Dahl OP, Stordal E, Lydersen S, Midgard R.

Mult Scler. 2009 Dec;15(12):1495-501. doi: 10.1177/1352458509351542. Epub 2009 Nov 13.

PMID:
19965515
29.

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.

Ljøstad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, Mygland A.

Lancet Neurol. 2008 Aug;7(8):690-5. doi: 10.1016/S1474-4422(08)70119-4. Epub 2008 Jun 21. Erratum in: Lancet Neurol. 2008 Aug;7(8):675.

PMID:
18567539
30.

Opsoclonus myoclonus syndrome in two cases with neuroborreliosis.

Skeie GO, Eldøen G, Skeie BS, Midgard R, Kristoffersen EK, Bindoff LA.

Eur J Neurol. 2007 Dec;14(12):e1-2. No abstract available.

PMID:
18028183
31.

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.

Grytten N, Glad SB, Aarseth JH, Nyland H, Midgard R, Myhr KM.

Neurology. 2006 Jan 24;66(2):182-6.

PMID:
16434650
32.

EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses.

Sellebjerg F, Barnes D, Filippini G, Midgard R, Montalban X, Rieckmann P, Selmaj K, Visser LH, Sørensen PS; EFNS Task Force on Treatment of Multiple Sclerosis Relapses.

Eur J Neurol. 2005 Dec;12(12):939-46.

PMID:
16324087
33.

[Retraction of article].

Midgard R, Seland JH, Hovdal H, Celius EG, Eriksen K, Jensen D, Heger H, Mellgren SI, Wexler A, Beiske AG, Myhr KM.

Tidsskr Nor Laegeforen. 2005 Aug 11;125(15):2056. Norwegian. No abstract available.

PMID:
16208878
34.

[The cooperation between Helse Midt-Norge and NTNU supports clinical research].

Farup PG, Edna TH, Hole T, Midgard R, Lydersen S, Kaasa S.

Tidsskr Nor Laegeforen. 2005 Sep 8;125(17):2382-3. Norwegian. No abstract available.

35.

Life-threatening acute pancreatitis associated with interferon beta-1a treatment in multiple sclerosis.

Midgard R, Ertresvåg K, Trondsen E, Spigset O.

Neurology. 2005 Jul 12;65(1):170-1. No abstract available.

PMID:
16009917
36.

[Optic neuritis--diagnosis, treatment and follow up].

Midgard R, Seland JH, Hovdal H, Celius EG, Eriksen K, Jensen D, Heger H, Mellgren SI, Wexler A, Beiske AG, Myhr KM.

Tidsskr Nor Laegeforen. 2005 Feb 17;125(4):425-8. Norwegian. Retraction in: Midgard R, Seland JH, Hovdal H, Celius EG, Eriksen K, Jensen D, Heger H, Mellgren SI, Wexler A, Beiske AG, Myhr KM. Tidsskr Nor Laegeforen. 2005 Aug 11;125(15):2056.

37.

Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study.

Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R.

Acta Neurol Scand. 2004 Jun;109(6):378-84.

PMID:
15147459
38.

[New diagnostic criteria in multiple sclerosis].

Midgard R, Beiske AG, Celius EG, Jensen D, Hovdal H, Mellgren SI, Myhr KM.

Tidsskr Nor Laegeforen. 2003 May 15;123(10):1345-8. Review. Norwegian. No abstract available.

PMID:
12806674
39.

[Lyme neuroborreliosis in More and Romsdal].

Eldøen G, Vik IS, Vik E, Midgard R.

Tidsskr Nor Laegeforen. 2001 Jun 30;121(17):2008-11. Norwegian.

40.

[Treatment of multiple sclerosis].

Midgard R.

Tidsskr Nor Laegeforen. 2001 Aug 20;121(19):2254. Norwegian. No abstract available.

41.

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.

Myhr KM, Riise T, Vedeler C, Nortvedt MW, Grønning R, Midgard R, Nyland HI.

Mult Scler. 2001 Feb;7(1):59-65.

PMID:
11321195
42.
43.

Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.

Filippini G, Brusaferri F, Sibley WA, Citterio A, Ciucci G, Midgard R, Candelise L.

Cochrane Database Syst Rev. 2000;(4):CD001331. Review.

PMID:
11034713
44.

Multiple sclerosis and cancer in Norway. A retrospective cohort study.

Midgard R, Glattre E, Grønning M, Riise T, Edland A, Nyland H.

Acta Neurol Scand. 1996 Jun;93(6):411-5.

PMID:
8836302
45.

Multiple sclerosis and chronic inflammatory diseases. A case-control study.

Midgard R, Grønning M, Riise T, Kvåle G, Nyland H.

Acta Neurol Scand. 1996 May;93(5):322-8.

PMID:
8800342
46.

Disability and mortality in multiple sclerosis in western Norway.

Midgard R, Riise T, Kvåle G, Nyland H.

Acta Neurol Scand. 1996 May;93(5):307-14.

PMID:
8800339
48.

Incidence of multiple sclerosis in Møre and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis.

Midgard R, Riise T, Svanes C, Kvåle G, Nyland H.

Brain. 1996 Feb;119 ( Pt 1):203-11.

PMID:
8624682
49.

Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway.

Midgard R, Albrektsen G, Riise T, Kvåle G, Nyland H.

J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):417-21.

50.

Absence of HTLV-1 related sequences in MS from high prevalence areas in western Norway.

Myhr KM, Frost P, Grønning M, Midgard R, Kalland KH, Helland DE, Nyland HI.

Acta Neurol Scand. 1994 Jan;89(1):65-8. Erratum in: Acta Neurol Scand 1994 Aug;90(2):143.

PMID:
8178631

Supplemental Content

Loading ...
Support Center